OPTIONS AND AWARDS (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Assumptions for Stock Options Granted |
The Company used the following assumptions for stock options granted during the three months ended June 30, 2026 and 2025: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Grant Year | | Options Granted | | Weighted Average Risk-Free Rate | | Expected Life | | Weighted Average Volatility | | | | Weighted Average Dividend Yield | | | | 2026 | | 197 | | 4.2% | | 6.2 years | | 37.9% | | | | 0.1% | | | | 2025 | | 175 | | 4.2% | | 6.2 years | | 39.1% | | | | 0.2% | | | | | | | | | | | | | | | | | |
The Company used the following assumptions for stock options granted during the six months ended June 30, 2026 and 2025: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Grant Year | | Options Granted | | Weighted Average Risk-Free Rate | | Expected Life | | Weighted Average Volatility | | Weighted Average Dividend Yield | | 2026 | | 509 | | 3.9% | | 6.2 years | | 38.2% | | 0.1% | | 2025 | | 327 | | 4.2% | | 6.2 years | | 39.4% | | 0.2% | | | | | | | | | | | |
|
| Schedule of Exercise Price and Fair Value Displayed at Grant Date for Stock Option Grants |
For the six months ended June 30, 2026 and 2025, the following represents the exercise price and fair value displayed at grant date for stock option grants: | | | | | | | | | | | | | | | | | | | | | | Grant Year | | Granted | | Weighted Average Exercise Price | | Weighted Average Fair Value of Options | | 2026 | | 509 | | $ | 199.28 | | | $ | 87.28 | | | 2025 | | 327 | | $ | 137.42 | | | $ | 61.71 | | | | | | | | |
|
| Schedule of Employee Stock Option Roll Forward |
The following table represents the employee stock option activity during the six months ended June 30, 2026: | | | | | | | | | | | | | | | | | | | | | | | | | Number of Options Outstanding | | Weighted Average Exercise Price | | Number of Options Vested | | Weighted Average Exercise Price of Options Vested | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | January 1, 2026 | 4,071 | | | $ | 96.87 | | | 1,991 | | | $ | 67.10 | | | Granted | 509 | | | 199.28 | | | | | | | Forfeited | (43) | | | 127.12 | | | | | | | Exercised | (254) | | | 62.45 | | | | | | | June 30, 2026 | 4,283 | | | $ | 110.77 | | | 2,042 | | | $ | 73.22 | |
|
| Schedule of Aggregate Intrinsic Value of Options |
The aggregate intrinsic value of options outstanding, vested, expected to vest and exercised as of June 30, 2026 and December 31, 2025 is as follows: | | | | | | | | | | | | | | | | | | | | | Options | | June 30, 2026 | | December 31, 2025 | | | | | | | | | | | | | | | | | | Outstanding | | $ | 239,432 | | | $ | 317,984 | | | | | Vested | | 177,815 | | | 213,189 | | | | | Expected to vest | | 58,481 | | | 98,487 | | | | | | | | | | |
|
| Schedule of Nonvested Restricted Stock Awards |
A summary of the status of the Company's non-vested restricted stock awards as of June 30, 2026 and changes during the six months ended June 30, 2026 is presented below: | | | | | | | | | | | | | Non-Vested Restricted Awards | | Weighted Average Grant Date Fair Value | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Nonvested at January 1, 2026 | 436 | | | $ | 129.54 | | | Granted | 205 | | | 203.09 | | | Vested | (142) | | | 156.12 | | | Forfeited | (9) | | | 123.94 | | Nonvested at June 30, 2026 | 490 | | | $ | 152.85 | |
|
| Schedule of Stock-Based Compensation Expense |
Stock-based compensation expense recognized for the Company's equity incentive plans and long-term incentive plan for the three and six months ended June 30, 2026 and 2025 was as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | | 2026 | | 2025 | | 2026 | | 2025 | | | | Stock-based compensation expense related to stock options | $ | 9,456 | | | $ | 7,402 | | | $ | 18,108 | | | $ | 14,207 | | | | | Stock-based compensation expense related to restricted stock awards | 4,727 | | | 3,761 | | | 9,107 | | | 7,163 | | | | Stock-based compensation expense related to restricted stock awards to non-employee directors | 713 | | | 465 | | | 1,374 | | | 949 | | | | | Stock-based compensation expense related to performance stock units | 1,066 | | | — | | | 1,066 | | | — | | | | | TOTAL | $ | 15,962 | | | $ | 11,628 | | | $ | 29,655 | | | $ | 22,319 | | | |
|